28 Aug 24	SSY Announces 2024 Interim Results, Net Profit HK$686 Million; Interim Dividend HK$0.08/Share, Actively Respond to Industry New Trends; Strive for Better Performance Result
27 Mar 24	Press Release (Chinese Version Only)

29 Aug 23	SSY Announces 2023 Interim Results, Net Profit HK$639 Million; Interim Dividend HK$0.07/Share, Determined to Seize Opportunities; Maintain Stable & Healthy Development
28 Mar 23	SSY Announces 2022 Annual Results, Net Profit up Approx. 43% To HK$1,123 Million; Final Dividend HK$0.08/Share, Revenue Sets Record High; Seize New Development Opportunities
03 Jan 23	Press Release (Chinese Version Only)

19 Dec 22	Press Release (Chinese Version Only)
12 Dec 22	Press Release (Chinese Version Only)
29 Aug 22	SSY Announces 2022 Interim Results, Net Profit HK$570 Million; Interim Dividend HK$0.06/Share, Seize Development Opportunities; Enhance Competitive Strength
29 Mar 22	SSY Group Limited Announces 2021 Annual Results, Net Profits up 28% to HK$786 Million with Final Dividend HK$0.07/Share, Promote Scientific Research Innovation; Optimisation of Product Mix

27 Aug 21	SSY Group Limited Announces 2021 Interim Results, Net Profits HK$276 Million; Interim Dividend HK$0.05/Share, Continuous Innovation & Scientific Research; Whole-Industry-Chain Approach Development
30 Mar 21	SSY Group Limited Announces 2020 Annual Results, Net Profits Drop 46% to Hk$612 Million with Final Dividend Hk$0.05/Share, Adjust Product Mix Actively; Strive for Innovative Breakthroughs

25 Aug 20	SSY Group Limited Announces 2020 Interim Results, Net Profits Drop 55% to HK$247 Million with Interim Dividend HK$0.05/Share, Keep Composure Facing Outbreak of the Novel Coronavirus, Strive to Make New Innovative Breakthroughs
30 Mar 20	SSY Group Limited Announces 2019 Annual Results, Net Profits Up 25% to HK$1136 Million with Final Dividend HK$0.06/Share, Continuous Improvements in Operating Results, Benefits from Business Diversification Emerged

26 Aug 19	SSY Group Limited Announces 2019 Interim Results, Net Profits Up 23% to HK$548 Million with Interim Dividend HK$0.05/Share, Continuously Kept Leading Position in the Industry, Dynamics of R&D and Bulk Pharmaceuticals Projects Emerged
13 Mar 19	SSY Group Limited Announces 2018 Annual Results, Net Profits up 37% to HK$912 Million with Final Dividend HK$0.05/Share, Results Reaching Historic High; Continuous Achievements from Innovations

27 Aug 18	SSY Group Limited Announces 2018 Interim Results, Net Profits Up 55% to HK$446 Million with Interim Dividend HK$0.04/Share, Growth in Sales Volume and Price from a Better Product Mix, Continuous Achievements from Innovations
27 Mar 18	Press Release (Chinese Version)

23 Aug 17	Press Release (Chinese Version)
29 Mar 17	Press Release (Chinese Version)

30 Aug 16	Press Release (Chinese Version)

01 Sep 15	Press Release (Chinese Version)
27 Mar 15	Announces 2014 Annual Results, Significant Growth in Profit Attribute to Equity Holders, Special Dividend of HK$0.172 per Share

28 Aug 14	Lijun International Announces 2014 Interim Results, Net Profit Increased Significantly by 32.2% to HK$301 Million

29 Aug 13	Lijun International Announces 2013 Interim Results
02 Apr 13	Lijun International Announces 2012 Annual Results

21 Aug 12	Lijun International Announces 2012 Interim Results
26 Mar 12	Announcement of 2011 Annual Results

26 Aug 11	Announcement of 2011 Interim Results

10 May 10	Ministry of Health 'Influenza A (H1N1) Treatment Proposal (2010 Version)' Suggested Using Arbidol Hydrochloride A Drug Developed and Researched by Lijun International Pharmaceutical (2005.hk)
30 Mar 10	Announcement of 2009 Annual Results Profit Attributable to Equity Holders was Raised 111.6% to HK$216 million as Compared to 2008

28 Aug 2009	Announcement of 2009 Interim results Profit Attributable to Equity Holders was Raised 9.9% to HK$112 million as Compared to 2008